Kelly Gold Biography and Net Worth

Chief Financial Officer of CAMP4 Therapeutics

Ms. Gold is the Chief Financial Officer at CAMP4 Therapeutics. She is responsible for guiding and executing the company’s strategy for establishing innovative strategic and technology-based partnerships that allow CAMP4 to realize the full value of the regRNA targeting approach. In addition, Ms. Gold leads all corporate finance and accounting, investor relations and strategic financial planning activities at CAMP4.

Ms. Gold joined CAMP4 in 2017 and has held roles of increasing responsibility leading the Business Development and Finance functions, most recently as Chief Business Officer and SVP, Finance. Prior to joining CAMP4, Ms. Gold held various roles in corporate finance and business planning at Biogen, where she provided financial leadership for the company’s late stage and marketed rare disease programs and developed long term strategic financial trajectories for the R&D organization. Prior to Biogen, Ms. Gold worked in the Healthcare and Latin American Investment Banking groups at Deutsche Bank. Ms. Gold began her career as a mechanical engineer designing biocontainment systems for Biosafety Level 4 research facilities.

Ms. Gold holds Bachelor’s degrees in Biochemistry and Mechanical Engineering from Queen’s University in Ontario, as well as an MBA from the MIT Sloan School of Management.

What is Kelly Gold's net worth?: The estimated net worth of Kelly Gold is at least $285.76 thousand as of September 11th, 2025. Ms. Gold owns 67,877 shares of CAMP4 Therapeutics stock worth more than $285,762 as of July 16th. This net worth evaluation does not reflect any other assets that Ms. Gold may own. Learn More about Kelly Gold's net worth.
How do I contact Kelly Gold?: The corporate mailing address for Ms. Gold and other CAMP4 Therapeutics executives is 15635 Alton Parkway Suite 250, Irvine CA, 92618. CAMP4 Therapeutics can also be reached via phone at (949) 600-5600 and via email at [email protected]. Learn More on Kelly Gold's contact information.
Has Kelly Gold been buying or selling shares of CAMP4 Therapeutics?: Kelly Gold has not been actively trading shares of CAMP4 Therapeutics over the course of the past ninety days. Most recently, on Thursday, September 11th, Kelly Gold bought 6,060 shares of CAMP4 Therapeutics stock. The stock was acquired at an average cost of $1.65 per share, with a total value of $9,999.00. Following the completion of the transaction, the chief financial officer now directly owns 67,877 shares of the company's stock, valued at $111,997.05. Learn More on Kelly Gold's trading history.
Who are CAMP4 Therapeutics' active insiders?: CAMP4 Therapeutics' insider roster includes Kurtis Binder (CFO), Jeffery Gardner (CEO), Kelly Gold (Chief Financial Officer), Josh Mandel-Brehm (President & Chief Executive Officer), and Amir Nashat (Director). Learn More on CAMP4 Therapeutics' active insiders.
Are insiders buying or selling shares of CAMP4 Therapeutics?: During the last twelve months, CAMP4 Therapeutics insiders bought shares 7 times. They purchased a total of 5,588,885 shares worth more than $8,554,993.77. The most recent insider tranaction occured on September, 11th when Major Shareholder Polaris Management Co. Vii, L. bought 1,307,189 shares worth more than $1,999,999.17. Insiders at CAMP4 Therapeutics own 21.7% of the company. Learn More about insider trades at CAMP4 Therapeutics.
Information on this page was last updated on 9/11/2025.

Kelly Gold Insider Trading History at CAMP4 Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/11/2025	Buy	6,060	$1.65	$9,999.00	67,877

Kelly Gold Buying and Selling Activity at CAMP4 Therapeutics

CAMP4 Therapeutics Company Overview

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California.

Today's Range

Now: $4.21

$4.17

$4.52

50 Day Range

MA: $4.28

$3.92

$4.56

2 Week Range

Now: $4.21

$1.32

$7.75

Volume

121,863 shs

Average Volume

319,609 shs

Market Capitalization

$218.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.1